ADIPOQ and type 2 diabetes mellitus: Lower circulating adiponectin levels have been observed in patients with obesity and type 2 diabetes compared with lean subjects, and have been associated with insulin sensitivity, lipid and glucose metabolism, and inflammation20,21.